Briefly, a midline incision was made on the ventral surface of the neck and the left common carotid artery isolated and ligated. Topical anaesthetic (EMLA, 5% prilocaine and lidocaine, AstraZeneca, UK) was applied to skin incision sites prior to incision. The internal carotid artery and the pterygopalatine artery were temporarily ligated. A 6-0 monofilament (Doccol, Sharon, MA, USA) was introduced into the internal carotid artery via an incision in the common carotid artery. The filament was advanced approximately 10 mm into the common carotid with the filament making its way distal to the carotid bifurcation, beyond the origin of the middle cerebral artery. A 10 mm mark was made on the filament to visualise the required length to be inserted beyond the carotid bifurcation. At 3 h from start of occlusion, animals were treated under isoflurane anaesthesia with vehicle (serum-free Mesenpro media), 9.1 × 104 IL-1α conditioned MSCs or 9.1 × 104 non-conditioned MSCs by intra-arterial infusion with a syringe driver (20 µl cell suspension, 0.5 µl/sec), via the filament incision site. Animals were recovered and returned to normal housing prior to behavioural testing.
Transient Focal Cerebral Ischemia Model
Briefly, a midline incision was made on the ventral surface of the neck and the left common carotid artery isolated and ligated. Topical anaesthetic (EMLA, 5% prilocaine and lidocaine, AstraZeneca, UK) was applied to skin incision sites prior to incision. The internal carotid artery and the pterygopalatine artery were temporarily ligated. A 6-0 monofilament (Doccol, Sharon, MA, USA) was introduced into the internal carotid artery via an incision in the common carotid artery. The filament was advanced approximately 10 mm into the common carotid with the filament making its way distal to the carotid bifurcation, beyond the origin of the middle cerebral artery. A 10 mm mark was made on the filament to visualise the required length to be inserted beyond the carotid bifurcation. At 3 h from start of occlusion, animals were treated under isoflurane anaesthesia with vehicle (serum-free Mesenpro media), 9.1 × 104 IL-1α conditioned MSCs or 9.1 × 104 non-conditioned MSCs by intra-arterial infusion with a syringe driver (20 µl cell suspension, 0.5 µl/sec), via the filament incision site. Animals were recovered and returned to normal housing prior to behavioural testing.
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization : University of Manchester
Other organizations : Salford Royal NHS Foundation Trust
Variable analysis
- Middle cerebral artery occlusion (MCAo) for 30 minutes
- Treatment with vehicle (serum-free Mesenpro media), 9.1 × 10^4 IL-1α conditioned MSCs or 9.1 × 10^4 non-conditioned MSCs by intra-arterial infusion
- Not explicitly mentioned
- Topical anaesthetic (EMLA, 5% prilocaine and lidocaine, AstraZeneca, UK) applied to skin incision sites prior to incision
- Internal carotid artery and the pterygopalatine artery temporarily ligated
- 6-0 monofilament (Doccol, Sharon, MA, USA) introduced into the internal carotid artery via an incision in the common carotid artery and advanced approximately 10 mm into the common carotid with the filament making its way distal to the carotid bifurcation, beyond the origin of the middle cerebral artery
- Positive control: Vehicle (serum-free Mesenpro media) treatment
- Negative control: Not explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!